VEGFA and metastatic colorectal cancer: Bevacizumab is a recombinant humanized monoclonal IgG antibody of VEGF that was approved for the treatment of metastatic colorectal cancer and is now also being used as an off-label therapeutic for eye diseases (Polizzi and Mahajan, 2015).